Brand Institute partners with Novaliq to develop the brand name VEVYE for their FDA-approved cyclosporine ophthalmic solution, which is designed to treat dry eye disease. VEVYE is a water-free cyclosporine eye drop formulation approved by the FDA for this purpose and was developed to address unmet needs in the market. The Brand Institute also worked on logo and packaging design for the product. The company has a portfolio of over 5,000 healthcare and consumer brands for more than 1,600 clients globally and partners on over 75% of pharmaceutical brand and nonproprietary name approvals every year. Their subsidiary, Drug Safety Institute, provides industry-leading guidance on drug name safety, packaging, and labeling.
Keywords: Brand Institute, Novaliq, VEVYE, FDA-approved, cyclosporine ophthalmic solution
VEVYE is a new innovative treatment that offers fast-acting relief from dry eye disease symptoms without using any anti-microbial preservatives or surfactants. The water-free formulation makes it unique compared to other treatments available in the market. The approval of VEVYE by the FDA will provide patients with an effective and well-tolerated therapy option. With its vast experience in branding healthcare products across